TickerFacts.

Ceribell, Inc. (CBLL): Shareholders' Equity

Annual figures by period end, from SEC filings.

$155.34M
As of 2025-12-31
$128.31M
As of 2026-06-30
$191.16M2023-12-31: -$112.25M2024-12-31: $191.16M2025-12-31: $155.34M$155.34M
2023-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$155.34M-18.7%2026-02-24, Balance as of period end
2024-12-31$191.16Mn/m2026-02-24, Balance as of period end
2023-12-31-$112.25Mn/a2025-02-25, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Ceribell, Inc. (CBLL)2025-12-31$155.34M-18.7%
Vaso Corp (VASO)2025-12-31$29.43M+6.2%
Biolife Solutions Inc (BLFS)2025-12-31$371.89M+6.6%
Electromed, Inc. (ELMD)2026-06-30$53.98M+24.9%
Outset Medical, Inc. (OM)2025-12-31$126.95M+373.4%
Iridex Corp (IRIX)2026-01-03$4.92M+134.7%
Axogen, Inc. (AXGN)2025-12-31$128.85M+24.0%
Stereotaxis, Inc. (STXS)2025-12-31$13.48M+121.7%
electroCore, Inc. (ECOR)2025-12-31-$1.71Mn/m

Compare CBLL, VASO, BLFS, ELMD side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗